arrow
C

Christopher G. Smith

university of helsinki
H指数:29
被引数:5,378

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A standardized framework for robust fragmentomic feature extraction from cell-free DNA sequencing data

一种用于从游离DNA测序数据中稳健提取片段组学特征的标准框架

2025-05-230
OA
Recurrence prediction using circulating tumor DNA in patients with early-stage non-small cell lung cancer after treatment with curative intent: A retrospective validation study

基于循环肿瘤DNA对接受根治性治疗后的早期非小细胞肺癌患者复发进行预测:一项回顾性验证研究

2025-04-150
OA
Predictive value of circulating tumor DNA (ctDNA) before and shortly after curative treatment in early stage non-small cell lung cancer (NSCLC), and exploration of (pre-)analytical factors

早期非小细胞肺癌(NSCLC)在根治性治疗前后循环肿瘤DNA(ctDNA)的预测价值,以及对(预)分析因素的探索

2024-09-010
PRE
CLEAR-Me: Interception trial to detect and clear molecular residual disease in patients with high-risk melanoma

CLEAR-Me:拦截试验,用于检测并清除高风险黑色素瘤患者的分子残留病灶

2024-09-012
PRE
Longitudinal ctDNA monitoring using a high sensitivity tumor-informed assay in patients with metastatic HR+/ HER2-breast cancer receiving endocrine therapy and CDK4/ 6 inhibitors
2024-03-220
PRE
Multimodal detection of molecular residual disease in high-risk locally advanced squamous cell carcinoma of the head and neck
2024-02-262
OAAI
Comparison of tumor-informed and tumor-naive sequencing assays for ctDNA detection in breast cancer

用于乳腺癌中ctDNA检测的肿瘤知情和未肿瘤测序分析的比较

2023-05-109
OAAI
A Phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA)
2022-06-2331
OA
Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancer

早期非小细胞肺癌患者治疗后残留ctDNA预测早期复发

2022-05-01150
OAAI
Fragmentation patterns and personalized sequencing of cell-free DNA in urine and plasma of glioma patients

胶质瘤患者尿液和血浆中游离DNA的片段化模式和个性化测序

2021-07-2271
OAAI
ctDNA detection in early stage non-small cell lung cancer
2020-08-150
PRE
ctDNA monitoring using patient-specific sequencing and integration of variant reads
2020-06-17122
OAAI
Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors
2020-02-2876
OAAI